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Background
Non-occlusive mesenteric ischemia (NOMI) is a rare but
severe complication. Early recognition of NOMI is difficult
due to its unspecific symptoms and the lack of specific
laboratory parameters. Prevention, diagnosis and optimal
therapy are under examinations.
Methods
Our aim was to evaluate the incidence of NOMI, to
analyze results of treatment and to identify variables
associated with mortality. Hospital records and clinical
data of patients treated for NOMI during the last 12 years
were reviewed. Clinical outcomes and factors influencing
mortality were studied. Statistical analysis was performed
to determine the significance of risk factors on mortality
with Fisher exact test or c2 test in categorical variables.
Wilcoxon rank test was used to test the continuous
variables.
Results
Between 7/2001and 6/2013 NOMI developed in 64 cases
(0.5%). Mean age of patients was 67.9±6.9 year. First
symptoms occurred 2.7±2 days after the operation.
Mesenteric artery angiography was performed in 59
patients (92.8%). After confirmation of mesenteric vasos-
pasm, a continuous infusion of 2.4 µg/h of prostagalandin
E1(PGE1) was administered in the superior mesenteric
artery. The 30-day mortality of NOMI after PGE1 treat-
ment was 66. Logistic regression analysis of risk factors
revealed preoperative NYHA stadium (P < 0.02), presence
of internal carotid artery stenosis (P < 0.05), prolonged
CPB and aortic cross clamp time P < 0.01), postoperative
arrhythmias (P < 0.05), reoperation (P < 0.03), use of arter-
enol and/or IABP ( P < 0.05), serum lactate level (P <
0.01), length of ventilation (P < 0.001 and number of
transfused red blood cell units (P < 0.05) were indepen-
dent predictors of mortality.
Conclusion
Mesenteric ischaemia in cardiac surgery remains a
devastating complication. A high index of suspicion with
prompt diagnostic evaluation may reduce the delay prior
to intervention. Early mesenteric angiography and
intraarterial PGE1 infusion seems to be useful to
improve survival.
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